Search results
Results from the WOW.Com Content Network
Prescription drug monitoring programs, or PDMPs, are an example of one initiative proposed to alleviate effects of the opioid crisis. [1] The programs are designed to restrict prescription drug abuse by limiting a patient's ability to obtain similar prescriptions from multiple providers (i.e. “doctor shopping”) and reducing diversion of controlled substances.
In Kentucky, for example, a law to improve monitoring of prescription practices, known as the Pill Mill Bill (KRS 218A.175 et seq.), has been in effect since 2012. [20] By 2012, 41 U.S. states had implemented such prescription monitoring program, and by 2019 all states except Missouri had implemented such programs. [21]
In the United States, there were approximately 109,600 drug-overdose-related deaths in the 12-month period ending January 31, 2023, at a rate of 300 deaths per day. [6] From 1999 to 2020, nearly 841,000 people died from drug overdoses, [7] with prescription and illicit opioids responsible for 500,000 of those deaths. [8]
A prescription monitoring program may help determine if an individual is ... the five states with the highest rates of death due to drug overdose were West Virginia ...
Surescripts is an American information technology company based in Arlington, Virginia that supports e-prescription, the electronic transmission of prescriptions between health care organizations and pharmacies, as well as general health information exchange (HIE) of medical records. [1]
Risk Evaluation and Mitigation Strategies (REMS) is a program of the US Food and Drug Administration for the monitoring of medications with a high potential for serious adverse effects. REMS applies only to specific prescription drugs, but can apply to brand name or generic drugs. [1] The REMS program was formalized in 2007.
Virginia governor orders schools to disclose details of school-related drug overdoses. MATTHEW BARAKAT. November 2, 2023 at 4:16 PM.
The National Council for Prescription Drug Programs (NCPDP) is an American nonprofit standards development organization representing most sectors of the U.S. pharmacy services industry. It was founded in 1977 as the extension of a Drug Ad Hoc Committee that made recommendations for the U.S. National Drug Code (NDC).